Hemodynamic Monitoring and Fluid Responsiveness in Venoarterial Extracorporeal Membrane Oxygenation (VA ECMO) - "HemodynamECMOnitoring-VA Study"

Launched by MEDICAL UNIVERSITY OF VIENNA · Sep 10, 2024

Keywords

ClinConnect Summary

The HemodynamECMOnitoring-VA Study is a clinical trial that aims to improve how doctors monitor blood flow and heart function in patients who are receiving a treatment called venoarterial extracorporeal membrane oxygenation (VA ECMO). This treatment helps supply oxygen-rich blood to vital organs when a person's heart or lungs are not working properly. The study will test the accuracy of different monitoring devices to see how well they work in this specific situation, as the artificial circulation used in ECMO may affect their performance.

To participate in this study, patients must be between 18 and 75 years old and currently receiving VA ECMO support. However, pregnant individuals and those with certain medical conditions, like recent trauma that prevents movement, cannot participate. If eligible, participants can expect to have their heart and blood flow monitored using various methods during their ECMO treatment. This research is important because it could lead to better care and outcomes for patients undergoing this life-saving procedure.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient receiving VA ECMO support
• • Age 18 - 75 years
• Exclusion Criteria:
• • Pregnancy
• • Conditions not allowing for passive leg raising maneuvers, e.g. "open abdomen", known or suspected elevation of intracranial pressure, recent leg or spinal trauma or orthopedic conditions not permitting leg raising
• • Known ischemic or hemorrhagic stroke within 3 months prior to study enrollment.